Algert Global LLC Grows Position in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Algert Global LLC boosted its position in Ryan Specialty Holdings, Inc. (NYSE:RYANFree Report) by 19.2% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 42,499 shares of the company’s stock after acquiring an additional 6,859 shares during the quarter. Algert Global LLC’s holdings in Ryan Specialty were worth $2,461,000 at the end of the most recent quarter.

Other institutional investors also recently added to or reduced their stakes in the company. Vanguard Group Inc. raised its holdings in shares of Ryan Specialty by 2.2% in the 4th quarter. Vanguard Group Inc. now owns 9,397,569 shares of the company’s stock valued at $404,283,000 after purchasing an additional 198,945 shares in the last quarter. Champlain Investment Partners LLC raised its stake in Ryan Specialty by 28.0% in the first quarter. Champlain Investment Partners LLC now owns 4,937,332 shares of the company’s stock valued at $274,022,000 after buying an additional 1,079,505 shares in the last quarter. Blair William & Co. IL raised its stake in Ryan Specialty by 3.4% in the second quarter. Blair William & Co. IL now owns 2,866,003 shares of the company’s stock valued at $165,970,000 after buying an additional 94,663 shares in the last quarter. Bessemer Group Inc. lifted its holdings in Ryan Specialty by 33.9% during the 1st quarter. Bessemer Group Inc. now owns 1,925,864 shares of the company’s stock worth $106,886,000 after buying an additional 488,067 shares during the last quarter. Finally, Bank of New York Mellon Corp boosted its position in shares of Ryan Specialty by 132.2% during the 2nd quarter. Bank of New York Mellon Corp now owns 836,209 shares of the company’s stock worth $48,425,000 after acquiring an additional 476,126 shares in the last quarter. Hedge funds and other institutional investors own 84.82% of the company’s stock.

Ryan Specialty Trading Up 2.7 %

NYSE RYAN opened at $68.20 on Wednesday. The firm’s fifty day moving average is $64.21 and its two-hundred day moving average is $57.86. Ryan Specialty Holdings, Inc. has a one year low of $41.49 and a one year high of $69.14. The company has a debt-to-equity ratio of 1.81, a quick ratio of 1.09 and a current ratio of 1.09. The firm has a market cap of $17.83 billion, a PE ratio of 128.68, a P/E/G ratio of 1.56 and a beta of 0.62.

Ryan Specialty (NYSE:RYANGet Free Report) last posted its quarterly earnings data on Thursday, August 1st. The company reported $0.58 EPS for the quarter, beating the consensus estimate of $0.56 by $0.02. Ryan Specialty had a return on equity of 48.08% and a net margin of 10.21%. The firm had revenue of $695.40 million during the quarter, compared to the consensus estimate of $695.56 million. During the same period in the prior year, the business earned $0.45 EPS. The firm’s revenue was up 18.9% compared to the same quarter last year. Analysts expect that Ryan Specialty Holdings, Inc. will post 1.81 earnings per share for the current year.

Ryan Specialty Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, August 27th. Investors of record on Tuesday, August 13th were issued a dividend of $0.11 per share. This represents a $0.44 annualized dividend and a dividend yield of 0.65%. The ex-dividend date was Tuesday, August 13th. Ryan Specialty’s dividend payout ratio is presently 83.02%.

Insider Activity at Ryan Specialty

In other news, President Timothy William Turner sold 2,000,000 shares of the firm’s stock in a transaction on Friday, August 9th. The shares were sold at an average price of $62.45, for a total value of $124,900,000.00. Following the completion of the sale, the president now owns 8,095 shares in the company, valued at approximately $505,532.75. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, EVP Jeremiah Rawlins Bickham sold 26,233 shares of Ryan Specialty stock in a transaction that occurred on Wednesday, August 14th. The stock was sold at an average price of $65.18, for a total value of $1,709,866.94. Following the sale, the executive vice president now directly owns 24,845 shares in the company, valued at $1,619,397.10. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, President Timothy William Turner sold 2,000,000 shares of the stock in a transaction on Friday, August 9th. The stock was sold at an average price of $62.45, for a total value of $124,900,000.00. Following the completion of the transaction, the president now owns 8,095 shares of the company’s stock, valued at approximately $505,532.75. The disclosure for this sale can be found here. Insiders have sold a total of 2,107,136 shares of company stock worth $131,860,032 in the last three months. Insiders own 11.10% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on RYAN shares. UBS Group raised their target price on Ryan Specialty from $67.00 to $76.00 and gave the stock a “buy” rating in a research report on Tuesday, August 13th. JPMorgan Chase & Co. boosted their price objective on shares of Ryan Specialty from $54.00 to $56.00 and gave the stock an “underweight” rating in a research report on Friday, August 2nd. Wells Fargo & Company increased their target price on shares of Ryan Specialty from $60.00 to $63.00 and gave the company an “equal weight” rating in a research report on Friday, August 2nd. Keefe, Bruyette & Woods reissued an “outperform” rating and issued a $62.00 price target on shares of Ryan Specialty in a research report on Tuesday, July 2nd. Finally, Barclays started coverage on shares of Ryan Specialty in a research note on Wednesday, September 4th. They issued an “overweight” rating and a $76.00 price objective for the company. One analyst has rated the stock with a sell rating, five have issued a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat, Ryan Specialty presently has an average rating of “Hold” and a consensus price target of $66.78.

Get Our Latest Stock Report on Ryan Specialty

Ryan Specialty Profile

(Free Report)

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

Featured Articles

Want to see what other hedge funds are holding RYAN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ryan Specialty Holdings, Inc. (NYSE:RYANFree Report).

Institutional Ownership by Quarter for Ryan Specialty (NYSE:RYAN)

Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.